QSC RESEARCH GRADE
≥99% HPLC PurityMS ConfirmedJanoshik COAIn-House SPPS1-Region Domestic Shipping
What is SLU-PP-332?
SLU-PP-332 50mg provides high-dose ERRα/ERRγ agonism in tablet form. At this concentration, research protocols can evaluate sustained receptor activation, downstream gene network saturation, and any off-target activity that emerges at pharmacological excess. Research use only.
Research Applications
High-Dose ERR Saturation
Maximal receptor occupancy, Emax plateau, selectivity profiling at saturation
Off-Target Safety Profiling
Selectivity panel at high dose — ERRβ, ERα, ERβ, other nuclear receptors
Sustained Mitochondrial Activation
Prolonged biogenesis program, mitophagy balance, mtDNA integrity
In Vivo Metabolic Studies
High-dose oral bioavailability, tissue distribution, hepatic first-pass at 50mg
Toxicology Reference
High-dose safety profiling, hepatotoxicity screening, biomarker response
Quick Specs
| Form | Tablet — 50mg per tablet, 100-tablet bottle |
| CAS Number | 2411025-13-3 |
| Molecular Formula | C₂₄H₂₃N₃O₃ |
| Molecular Weight | 405.5 g/mol |
| Compound Type | ERRα/ERRγ Nuclear Receptor Agonist |
| Purity | ≥99% by HPLC — every batch |
| Identity | MS molecular weight confirmed — every batch |
| COA | Janoshik-independent, publicly verifiable |
| Manufacture | In-house synthesis — Qingdao, China |
| Storage | Room temperature sealed | cool, dry storage |
| Shelf Life | 24 months unopened |

